Icahn School of Medicine at Mount Sinai

Clinical research site in Houston, Texas

As of July 2026, 1 paid clinical trial is recruiting at Icahn School of Medicine at Mount Sinai in Houston, Texas. Active studies at this site focus on Parkinson Disease alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Icahn School of Medicine at Mount Sinai (1)

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

for Parkinson Disease

27 locations incl. Phoenix

Sponsor: Impax Laboratories, LLC

Sex: All·Age: 18+

Code: NCT06765668·Phase 4·Recruiting·Listed Jan 2025

Apply to this trial

More research sites in Houston

MD Anderson Cancer Center (422 trials)
M D Anderson Cancer Center (272 trials)
Baylor College of Medicine (197 trials)
The University of Texas Health Science Center at Houston (185 trials)
The University of Texas MD Anderson Cancer Center (131 trials)
Houston Methodist Hospital (128 trials)
Texas Children's Hospital (113 trials)
The University of Texas M. D. Anderson Cancer Center (85 trials)
University of Texas MD Anderson Cancer Center (83 trials)
UT MD Anderson Cancer Center (62 trials)

Explore more

Paid clinical trials in Houston, TX · Texas clinical trials